SGT University Gurgaon Master of Pharmacy [M.Pharm] Pharmaceutical Regulatory Affairs: Fees 2026, Course Duration, Dates, Eligibility

Ans. M.Pharm in Pharmaceutical Regulatory Affairs focuses specifically on the regulatory aspects of drug development and approval, covering topics like CDSCO/DCGI regulations, US FDA guidelines, ICH guidelines, clinical trial regulations, and regulatory documentation. It prepares students for roles in regulatory affairs departments of pharma companies, regulatory agencies, and consulting firms. M.Pharm in Pharmacy Practice, on the other hand, focuses on clinical pharmacy, patient counselling, and hospital pharmacy management. The choice depends on whether you want to work in the regulatory/compliance domain or in clinical/hospital settings.

Ans. Yes, SGT College of Pharmacy is approved by the Pharmacy Council of India (PCI) and the programme follows PCI regulations for M.Pharm admissions, including the eligibility criteria of 55% marks in B.Pharm (50% for SC/ST candidates). The university is also NAAC A+ accredited. PCI approval ensures that the degree is recognised across India for employment in pharmaceutical companies, regulatory agencies, and academic institutions.

Ans. Graduates of M.Pharm in Pharmaceutical Regulatory Affairs are in high demand in India's pharmaceutical industry, which is the third largest in the world by volume. Career roles include Regulatory Affairs Officer, Drug Regulatory Specialist, Pharmacovigilance Specialist, Clinical Research Associate, Medical Writer, Quality Assurance Officer, and Drug Safety Associate. Top recruiters include multinational companies like Amneal Pharmaceuticals, Bristol Myers Squibb, Medtronic, Merck, Aurobindo Pharma, Zydus Lifesciences, Abbott, and IPCA Laboratories. Regulatory professionals with M.Pharm qualifications typically command starting salaries ranging from INR 3.5 to 6 lakhs per annum, with significant growth potential.

Ans. The seat intake for M.Pharm programmes at SGT University is limited, approximately 6 seats per specialisation as per PCI norms. This limited intake ensures personalised mentorship and focused learning. Admission is merit-based, primarily on B.Pharm marks, followed by a Personal Interview. Since the seats are limited, candidates with strong academic records (above 70% in B.Pharm) and clear career goals in regulatory affairs have a good chance of securing admission. It is advisable to apply early as seats fill up quickly.

Ans. As per PCI regulations, M.Pharm admissions require a B.Pharm degree from a PCI-recognised institution. Distance learning B.Pharm programmes are generally not recognised by PCI for the purpose of M.Pharm admission. Candidates with B.Pharm from regular (full-time) PCI-approved programmes are eligible. If you are unsure about the recognition status of your B.Pharm degree, it is advisable to contact SGT University's admissions office directly or check with PCI before applying.

Ans. M.Pharm students at SGT University undertake a significant research project as part of their curriculum, conducted under the guidance of experienced faculty members. The research focuses on specific areas of pharmaceutical regulatory affairs, such as regulatory submissions, pharmacovigilance studies, or clinical trial documentation. SGT College of Pharmacy has well-equipped research laboratories and the university's broader research infrastructure, including access to scientific databases and collaboration with industry partners. Faculty members have published research in peer-reviewed journals, providing students with strong mentorship for their research projects.